Bookmarks
CCU028: Coronary revascularisation and outcomes before and after the COVID-19 pandemic
Safe People
Organisation name
University of Glasgow
Organisation sector
Academic Institute
Applicant name(s)
Colin Berry
Sub-licence arrangements (if any)?
No
Safe Projects
Project ID
CCU028
Lay summary
Angina is a chronic heart condition that has a substantial impact on our health and social services, and on the population, society and the economy. Treatment with a coronary stent (thin metal tube) is intended to relieve angina, and around 100,000 people are treated with a stent in the NHS each year. Coronary artery bypass graft (CABG) surgery is reserved for patients with extensive coronary atherosclerosis – a condition where arteries become clogged with fatty substances called plaques, or ‘atheroma’. Around 14,000 patients undergo CABG in the NHS each year. In this study, we will focus on angina and stents. Recent research has suggested that around 2 in 5 patients report angina within one year of receiving a stent. This implies that a considerable number of patients in the UK may be affected – potentially around 40,000 people each year. The underlying reasons for this are currently under-researched and poorly understood. The explanations may include problems with the small vessels within the heart muscle that lead to a condition called ‘microvascular angina’. Stents do not help with small vessel problems, and in fact, may even make small vessel problems worse. COVID-19 infection leads to heart and blood vessel injury. Whether COVID-19 infection impacts on angina and clinical outcomes, including in patients who have received a coronary stent, is unknown. This research will focus on angina before and after COVID-19 infection. The research will also assess angina occurring after stents in patients who have had COVID-19 infection. Advances in linked electronic patient records now enable studies of episodes of care in hospital and at the GP. We will therefore study NHS data at a national (UK) level. We will assess the number (%) of patients who attend their GP and hospitals for angina, including after receiving a stent, and we will estimate the NHS costs attached to these visits and medication use. We wish to make these assessments before, during and after the COVID-19 pandemic by examining a period of at least 10-years before and at least 5-years after the pandemic. This should provide sufficient information to assess the impact of angina, including after stent treatment in the NHS before, during and after the COVID-19 pandemic.
Public benefit statement
We will assess the costs and health economic impact associated with these episodes of care, and their changes over time. We will then estimate whether alternative treatment approaches could be cost-effective for the NHS. A future study is anticipated to assess the effects of COVID-19 infection status on anginal symptoms in patients following CABG. Visit the BHF Data Science Centre website for more detailed information about project outputs. https://bhfdatasciencecentre.org/projects/ccu028/
Technical summary
This project accessed the following datasets within the Trusted Research Environment(s) for CVD-COVID-UK / COVID-IMPACT: - ENGLAND: - Civil Registration - Deaths - COVID-19 SARI-Watch (formerly CHESS) - Covid-19 Second Generation Surveillance System - Covid-19 UK Non-hospital Antibody Testing Results - Covid-19 UK Non-hospital Antigen Testing Results - COVID-19 Vaccination Adverse Reaction - COVID-19 Vaccination Status - Emergency Care Data Set (ECDS) - GPES Data for Pandemic Planning and Research (COVID-19) - Hospital Episode Statistics Accident and Emergency - Hospital Episode Statistics Admitted Patient Care - Hospital Episode Statistics Critical Care - Hospital Episode Statistics Outpatients - ICNARC: Intensive Care National Audit and Research Centre - Medicines dispensed in Primary Care (NHSBSA data) - NICOR – MINAP: Myocardial Ischaemia National Audit Project - NICOR – NHFA: National Heart Failure Audit - NICOR – PCI: Percutaneous Coronary Interventions - Secondary Care Prescribed Medicines (EPMA) - Secondary Uses Services Payment By Results - Sentinel Stroke National Audit Programme Clinical Dataset - WALES: - Annual District Death Daily (ADDD) - Annual District Death Extract (ADDE) - Care Home Dataset (CARE) - Covid Vaccination Dataset (CVVD) - COVID-19 Consolidated Deaths (CDDS) - COVID-19 Shielded People List (CVSP) - COVID-19 Test Results (PATD) - COVID-19 Test Trace and Protect (CTTP) - Legacy - Critical Care Dataset (CCDS) - Emergency Department Dataset (EDDS) - Emergency Department Dataset Daily (EDDD) - Intensive Care National Audit and Research Centre (ICCD) - Legacy - COVID only - Intensive Care National Audit and Research Centre (ICNC) - Maternity Indicators Dataset (MIDS) - Outpatient Database for Wales (OPDW) - Outpatient Referral (OPRD) - Patient Episode Dataset for Wales (PEDW) - Referral to Treatment Times (RTTD) - SAIL Dementia e-Cohort (SDEC) - Welsh Ambulance Services NHS Trust (WASD) - Welsh Demographic Service Dataset (WDSD) - Welsh Dispensing Dataset (WDDS) - Legacy - Welsh Longitudinal General Practice Dataset (WLGP) - Welsh Primary Care - Welsh Longitudinal GP Dataset - Welsh Primary Care (Daily COVID codes only) (GPCD) - Welsh Results Reports Service (WRRS)
Latest approval date
08/11/2021
Safe Data
Dataset(s) name
Data sensitivity level
De-Personalised
Safe Setting
Access type
TRE